News & Articles

Which new product, instrument or consumable has made the most difference to your lab? Nominate now for a chance to win a $500 Amazon voucher

Professor Jack Gilbert, Director of the Microbiome Center at the University of Chicago, explores the value of exploiting personal microbiomes to solve crime

Single chemistry system extracts total nucleic acid, DNA and/or RNA from single FFPE tissue sample

Register now to discover new, expert perspectives on process design, scale-up, and product safety

Josh Haimes, technical lead at ArcherDX, explains how successful NGS is influenced by step-by-step quality control

From cancer cells to ocean microbes to Zika virus: Read the interviews that made the most impact in 2017

Failures brought to light by botched police investigation have led to tough new requirements for the manufacturers of DNA analysis products

TruePrimE cfDNA kit promises superior selectivity and preferential amplification

Dr. Michael Bianchi, senior lab manager at Empire Genomics explains the fundamental basis of a successful experiment – a protocol that works well.

Learn how to optimize FFPE sample preparations to enable successful downstream assays

Dr. Andy Golden, senior investigator at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), explores the value of C. elegans as an animal model for research

Melanoma researcher selected as the winner of ‘RNAscope ISH Get Hybridized’ giveaway, supporting cutting-edge research

Range of liquid format recombinase polymerase amplification kits are ideal for rapid testing applications and high-throughput laboratory use

Dolomite Bio has announced the launch of the game-changing Nadia single-cell platform

The foodproof Beer Screening LyoKit can detect 31 different bacteria in one test

Labcyte Inc., Wyatt Technology Corp., Erlab Inc., Specac and Bertin Instruments among the recipients as more top-rated products gain a coveted SelectScience Seal of Quality

Dr. Stephen Chanock, National Cancer Institute, shares the latest cancer epidemiology studies at the NIH and the team’s hopes of being able to predict and prevent disease